The Kallikrein Panel for prostate cancer screening: its economic impact.

@article{Voigt2014TheKP,
  title={The Kallikrein Panel for prostate cancer screening: its economic impact.},
  author={Jeffrey Voigt and Stephen M Zappala and Jr E. Darracott Vaughan and Alan J. Wein},
  journal={The Prostate},
  year={2014},
  volume={74 3},
  pages={
          250-9
        }
}
BACKGROUND Current diagnostic testing for prostate cancer results in numerous unnecessary biopsy procedures and creates a substantial financial burden. A statistical prediction model for prostate cancer has been developed, based on four Kallikrein markers in blood. This systematic review and meta-analysis examines the aggregated results from published studies of the Kallikrein Panel. METHODS Literature searches to identify relevant studies were conducted. A meta-analysis of the results was… CONTINUE READING
2
Twitter Mentions

Citations

Publications citing this paper.
SHOWING 1-10 OF 16 CITATIONS

Screening for prostate cancer: moving forward in the molecular era.

  • Journal of B.U.ON. : official journal of the Balkan Union of Oncology
  • 2018
VIEW 1 EXCERPT
CITES BACKGROUND

PSA and beyond: alternative prostate cancer biomarkers

  • Cellular Oncology
  • 2016
VIEW 1 EXCERPT
CITES BACKGROUND

Recent progress and perspectives on prostate cancer biomarkers

  • International Journal of Clinical Oncology
  • 2016
VIEW 1 EXCERPT
CITES BACKGROUND